European Archives - Page 1097 of 1516 - European Medical Journal

Cutaneous Adverse Effects Induced by Nivolumab

Nivolumab is a humanised IgG4 monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligand…

Erythema Multiforme: A Clinical Study of Thirty-Two Patients

Erythema multiforme (EM) is an acute, immune-mediated skin condition that infection or medication can trigger. It occurs most frequently in young adults…

Combined Treatment of Acneiform Rash Involved in Epidermal Growth Factor Receptor Inhibitors Therapy

Acneiform rash has a great influence on patient quality of life. Such severe dermatologic reactions are induced by epidermal growth factor receptor…

ESC 2019 – Interview – Dr Donald Lloyd-Jones

An interview with Dr Donald Lloyd-Jones, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Illinois, USA.

Edge-to-Edge Repair After Prior Left-Sided Pneumonectomy

Cardiac procedures and operations following pneumonectomy present with serious challenges, both surgical and anaesthetic…

The Potential of Biomedical Engineering in Respiratory Health

During this year’s European Society of Respiratory (ERS) International Congress, we spoke to Prof Geoffrey Maksym, Director, Professor, School…

Deep Stages of Sleep May Help to Reduce Anxiety Levels

DISTURBED sleep throughout the night can increase anxiety levels by up to 30%, and the phase of deep sleep is a natural form of relief for anxiety…

Prediction of Alzheimer’s Disease from Cognitive Testing in Childhood

EXPLORATION of factors that influence cognitive ability could help to minimise cognitive decline and risk of dementia. Such factors were investigated…

Raiders of the Lost Wire

An angiographic guidewire is a basic, yet key piece of equipment in the interventional cardiologist’s armamentarium. The complications associated…

Association Between Leukocyte Telomere Length and Functional Decline in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment

Patients with idiopathic pulmonary fibrosis (IPF) display an unpredictable and heterogeneous disease behaviour with a progressive functional decline…